BioCentury
ARTICLE | Company News

Chaperone Technologies, MerLion deal

December 14, 2009 8:00 AM UTC

The companies will evaluate the combination of Chaperone's preclinical small molecule heat shock protein 70 (Hsp70) inhibitors with MerLion's finafloxacin as potential treatments for bacterial infect...